Lobbying Governance
Overall Assessment | Analysis | Score |
---|---|---|
None |
Luye Pharma maintains a structured ESG governance framework, with an “ESG Committee” that “conducts annual assessments and evaluations of its own performance and the adequacy of its term of reference” and an “ESG Working Group” responsible for “the specific implementation of all ESG work and management”; however, the company does not disclose any internal mechanisms for governing or aligning direct or indirect lobbying activities, nor any specific individual or formal body overseeing lobbying, and we found no evidence of climate-related lobbying governance processes.
View Sources
|
E |